NFKB1 and type 1 diabetes mellitus: Postbiotics, such as sodium butyrate, have shown promise in glycaemic control by improving islet morphology and downregulating the NF-κB–mediated inflammatory signalling pathway in streptozotocin-induced T1D mice.